These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6103057)

  • 1. Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats.
    Finch L; Hicks PE
    J Pharm Pharmacol; 1980 Apr; 32(4):272-7. PubMed ID: 6103057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central administration of tiamenidine and clonidine in normotensive and chronically renal hypertensive animals].
    Lindner E; Schölkens BA
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():234. PubMed ID: 613585
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.
    Salzmann R
    J Pharm Pharmacol; 1979 Apr; 31(4):212-6. PubMed ID: 36458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment.
    Gerlis LS; Wright N
    Pharmatherapeutica; 1980; 2(6):408-11. PubMed ID: 7001495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The withdrawal of centrally acting antihypertensives in dogs.
    Clough DP; Keddie J; Pettinger SJ
    Arzneimittelforschung; 1981; 31(11):1878-80. PubMed ID: 7198468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by clonidine (St-155) of cardiac arrhythmias induced by digitalis.
    Gillis RA; Dionne RA; Standaert FG
    J Pharmacol Exp Ther; 1972 Aug; 182(2):218-26. PubMed ID: 5048360
    [No Abstract]   [Full Text] [Related]  

  • 9. Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):82-6. PubMed ID: 7050735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal syndrome upon cessation of chronic clonidine treatment in rats.
    Dix RK; Johnson EM
    Eur J Pharmacol; 1977 Jul; 44(2):153-9. PubMed ID: 18357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension.
    Campbell BC; Elliott HL; Hamilton CA; Reid JL
    Eur J Clin Pharmacol; 1980 Nov; 18(6):449-54. PubMed ID: 7461012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of central administration of clonidine in conscious cats.
    Ally A
    Brain Res; 1997 Jul; 761(2):283-9. PubMed ID: 9252027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrupt cessation of clonidine administration: a prospective study.
    Whitsett TL; Chrysant SG; Dillard BL; Anton AH
    Am J Cardiol; 1978 Jun; 41(7):1285-90. PubMed ID: 665535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndrome after continuous infusion of clonidine in the normotensive rat.
    Thoolen MJ; Timmermans PB; Van Zwieten PA
    J Pharm Pharmacol; 1981 Apr; 33(4):232-5. PubMed ID: 6115906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of the mechanism of the clonidine withdrawal tachycardia in rats.
    Jonkman FA; Man PW; Thoolen MJ; van Zwieten PA
    J Pharm Pharmacol; 1985 Aug; 37(8):580-2. PubMed ID: 2864424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion and withdrawal of methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ; Hendriks JC; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(2):221-3. PubMed ID: 6188893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
    Barber ND; Reid JL
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of clonidine: effects of varying dosage or duration of treatment on subsequent blood pressure and heart rate responses.
    Oates HF; Stoker LM; Monaghan JC; Stokes GS
    J Pharmacol Exp Ther; 1978 Aug; 206(2):268-73. PubMed ID: 28415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.